Not applicableUnknownNCT01034891What this trial is testingWomen At Risk: The High Risk Breast Cancer ProgramWho this might be right forBreast Cancer New York Presbyterian Hospital 2,000
Early research (Phase 1)Study completedNCT00465725What this trial is testingA Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid TumorsWho this might be right forBladder CancerBreast CancerColorectal Cancer+6 more Poniard Pharmaceuticals 18
Early research (Phase 1)Study completedNCT00004074What this trial is testingInterleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuWho this might be right forAdvanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Ended earlyNCT05012397What this trial is testingMilademetan in Advanced/Metastatic Solid TumorsWho this might be right forSolid TumorsHead and Neck CarcinomaCholangiocarcinoma+15 more Rain Oncology Inc 40
Early research (Phase 1)Study completedNCT04045496What this trial is testingA First-in-Human, Phase 1 Study of JAB-3312 in Adult Patients With Advanced Solid TumorsWho this might be right forNon-small Cell Lung CancerColorectal CancerPancreatic Ductal Carcinoma+4 more Jacobio Pharmaceuticals Co., Ltd. 40
Early research (Phase 1)Looking for participantsNCT06451497What this trial is testingThis is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid TumorsWho this might be right forNon Small Cell Lung CancerHead and Neck Squamous Cell CarcinomaPancreas Adenocarcinoma+8 more Zumutor Biologics Inc. 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07623642What this trial is testingA Phase II Study of GV20-0251 in Combination With Anti-PD-1 Monoclonal Antibodies in Patients With Unresectable, Locally Advanced, or Metastatic Solid Tumors.Who this might be right forUterine Cervical NeoplasmsTriple Negative Breast NeoplasmsProstatic Neoplasms+8 more GV20 Therapeutics 227
Not applicableLooking for participantsNCT05334069What this trial is testingCollecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer DetectionWho this might be right forAcute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAnn Arbor Stage I Lymphoma+59 more Alliance for Clinical Trials in Oncology 2,000
Early research (Phase 1)Study completedNCT04148937What this trial is testingThe CD73 Inhibitor LY3475070 Alone or in Combination With Pembrolizumab in Participants With Advanced CancerWho this might be right forAdvanced Cancer Eli Lilly and Company 52
Testing effectiveness (Phase 2)Looking for participantsNCT05706129What this trial is testingAssess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid TumorsWho this might be right forClear Cell Renal Cell Cancer (ccRCC)Pancreatic Ductal Adenocarcinoma (PDAC)Colorectal Cancer (CRC)+6 more Lumara Bio Oncologics GmbH 270
Early research (Phase 1)Looking for participantsNCT07705334What this trial is testingSHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid TumorsWho this might be right forAdvanced or Metastatic Solid TumorsTriple Negative Breast Cancer (TNBC)HR+ Breast Cancer+8 more SHY Therapeutics 30
Not applicableLooking for participantsNCT05248763What this trial is testingTaiwan Cancer Moonshot ProjectWho this might be right forMalignant Neoplasm of Body of Stomach in Situ Academia Sinica, Taiwan 4,190
Early research (Phase 1)Study completedNCT03829436What this trial is testingTPST-1120 as Monotherapy and in Combination With Nivolumab in Subjects With Advanced CancersWho this might be right forHepatocellular CarcinomaMetastatic Castration Resistant Prostate CancerRenal Cell Carcinoma+9 more Tempest Therapeutics 38
Not applicableWithdrawnNCT04985357What this trial is testingDefining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to DrugsWho this might be right forStage III Breast CancerStage IV Breast CancerStage III Lung Cancer+35 more Travera Inc
Not applicableLooking for participantsNCT05059444What this trial is testingORACLE: Observation of ResiduAl Cancer With Liquid Biopsy EvaluationWho this might be right forBladder CarcinomaUreter CarcinomaRenal Pelvis Carcinoma+14 more Guardant Health, Inc. 2,285
Early research (Phase 1)UnknownNCT05498597What this trial is testingAMT-151 in Patients With Selected Advanced Solid TumoursWho this might be right forAdvanced Solid TumorAdvanced CancerAdvanced Carcinoma+16 more Multitude Therapeutics Inc. 30
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Not applicableUnknownNCT04267575What this trial is testingCanady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor SitesWho this might be right forRecurrent Malignant Solid NeoplasmStage IV Breast CancerStage IV Prostate Cancer+13 more Jerome Canady, M.D. 20
Not applicableStudy completedNCT03662204What this trial is testingBlood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid TumorsWho this might be right forBreast CancerLung CancerColorectal Cancer+10 more Exact Sciences Corporation 5,133
Not applicableLooking for participantsNCT07808164What this trial is testingENPP1/cGAS (EG) and FAP Expression Profiles in Solid Tumors: An Immunohistochemical Study in a Vietnamese CohortWho this might be right forHCC - Hepatocellular CarcinomaCRC (Colorectal Cancer)Gastric Carcinoma+5 more Tam Anh Research Institute 162